EP300 and cancer: In this regard, NASTRp can not only regulate the transcriptional regulation of CREB, but also other CBP/p300-interacting transcription factors and as such act as a broad anti-cancer agent, by regulating processes such as cell cycle progression, autophagy, ER stress and cell death.